TransCode Therapeutics, Inc. RNAZ

Full chart Compare
Set alert

Price alert · RNAZ

All alert types
1.57 USD -0.06 (-3.68%)

At closeNov 3, 2026, 4:02 PM EST

1.57 0.00 0.00%

After hours · Nov 3, 4:02 PM ET

1.50 Day range 1.61
1.50 52-week range 12.60
YTD
-77.01%
1 year
-85.06%

Analyst view

Consensus: buy

Buy
Price target (mean) 20.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 1
  • 2 months ago 1
  • 3 months ago 1

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RNAZ analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-3.21-3.21 – -3.21-627.33+99.5%300.00K0.0%1
Next quarter0.000.00 – 0.00-21.450.0%00.0%0
Current year-4.76-4.76 – -4.76-3,419.13+99.9%300.00K0.0%1
Next year-4.37-4.37 – -4.37-4.76+8.2%0-100.0%1

Upgrades and downgrades

The latest rating changes

RNAZ analyst upgrades and downgrades
DateFirmActionFromTo
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 29, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 3, 2024HC Wainwright & Co.ReiteratedBuyBuy